Generative language model that designs drug-like SMILES conditioned on disease ontology and a target protein sequence for de novo drug discovery.
Target-conditioned generative language model that designs drug-like SMILES from a protein sequence, tuned on regulator-approved drug-target pairs.
Isfahan University of Technology / Isfahan University of Medical Sciences
Released September 24, 2024
Protein druggability scoring that concatenates frozen ESM-2 sequence embeddings with Gene Ontology annotations to rank candidate drug targets.